CZI Pledges Billions More Dollars in Science Funding

Priscilla Chan and Mark Zuckerberg are dedicating a further $3.4 billion to biomedical and human health research on top of $3 billion invested several years ago, the organization announced this week.

| 2 min read
Cofounders and co-CEOs of the Chan Zuckerberg Initiative, Mark Zuckerberg and Priscilla Chan
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Aphilanthropic organization established by Facebook CEO Mark Zuckerberg and his wife Priscilla Chan will invest $3.4 billion in research to help cure, prevent, and manage human disease, according to a press statement released on Tuesday (December 7).

The money from the Chan Zuckerberg Initiative (CZI), which was founded in 2015, follows an earlier $3 billion investment and will be used to support scientific research over the next 10–15 years. Plans include establishing new research centers—such as an artificial intelligence institute at Harvard University and a biomedical imaging center with a yet-to-be determined location—as well as supporting collaborative projects such as the CZ Biohub Network, which will connect researchers working on disease mechanisms and therapies.

“Biomedical science and technology development hold tremendous promise to advance human health and treat disease,” Chan, a former pediatrician, says in the press statement. “Working as partners with scientists, patients, and open source communities, we’ve learned ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Catherine Offord

    Catherine is a science journalist based in Barcelona.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours